Search filters

Filters
Clear All

Phase

  • 5
  • 4
  • 2
  • 2
  • 6
  • 20
  • 6
  • 2
  • 18

Found 20 Vaccines trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Safety and Immunogenicity Study of SARS-CoV-2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls
18 years - 99 years
Accepts healthy volunteer
All genders
Phase 3
The research study is being conducted to study the effectiveness of the mRNA-1273 study vaccine in people who have received a kidney or liver transplant. Healthy participants are being included in the study to compare the results from these participants to those who have had a kidney or liver transplant. …
 A5369: HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) as Therapeutic Vaccination in HIV-Infected Persons with Viral Suppression on Antiretroviral Therapy
99 years or below
All genders
Phase 1
A5369 is a phase I/IIa, randomized, double-blind, placebo-controlled study to evaluate the safety, immunogenicity, and efficacy of p24CE/full-length Gag DNA, as a therapeutic vaccine in HIV-1 infected persons. The study targets to enroll 40 participants. All participants are well-suppressed on ART, current CD4 T cell counts greater than 500 cells/mm3, …
 Study of INO-5401 Alone or INO-5401 in Combination with INO-9012 Followed by Electroporation in Adults with BRCA1 or BRCA2 Mutations
18 years - 99 years
All genders
Phase 1
The research study is being conducted to test an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations. This study will test if the vaccine is safe (without significant side effects) and test a new way of administering vaccines. It will also test whether the vaccine …
 Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
18 years - 55 years
All genders
Phase 3
The research study is being conducted to learn whether an investigational drug called lebrikizumab could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD compared with placebo. Research procedures include: Physical exam, Medical History, blood and urine tests, …
 A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, andAnti-Tumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients with Selected SolidTumors
18 years - 99 years
All genders
To evaluate an investigational, personalized adjuvanted vaccine, GEN-009, that is being developed for the treatment of patients with solid tumors. A personalized vaccine, consisting of between 4 to 20 synthetic long peptides, will be generated for each patient and shall be administered as an adjuvanted vaccine, with the adjuvant Hiltonol.
18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.
18 years - 99 years
All genders
The purpose of the study is to find out whether an extra dose of COVID-19 study dose of vaccine will help to protect people who have had a liver or kidney transplant from COVID-19 by causing their body to make antibodies against the virus that causes COVID-19. Many transplant recipients …
18 years - 80 years
All genders
Observational
The research study is being conducted to study the Immune System, specifically, the immune reactions that take place in lymph nodes following either vaccination or infection. This study will be looking at vaccines and infection related to SARS-CoV-2. Procedures include: Blood draw and Fine Needle Aspiration of cervical (neck) and/or …
18 years - 99 years
All genders
Observational
Adult patients with Rheumatoid Arthritis, Psoriatic Arthritis, SLE, Sjogren’s Disease, Multiple Sclerosis, Scleroderma, Vasculitis or Blistering Diseases will undergo a blood draw and collection of clinical information prior to receipt of COVID-19 vaccination. Subjects will undergo a repeat blood draw and collection of clinical information at 4-10 weeks, 6 months …
11 - 20 of 20